Akèy › Kansè nan tete › Illinois › Waukegan
Etid klinik pou Kansè nan tete nan Waukegan, IL
12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Waukegan (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Ap rekriteFaz 2
- City of Hope Chicago, Zion · 6 mi lwen
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Ap rekriteFaz 1/2
- City of Hope, Chicago, Zion · 6 mi lwen
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Ap rekriteFaz 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi lwen
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
- City of Hope - Chicago, Zion · 6 mi lwen
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Ap rekriteFaz 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi lwen
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Ap rekriteFaz 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
- ak 1 plis
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Ap rekriteFaz 3
- City of Hope - Cancer Center Chicago, Zion · 6 mi lwen
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Midwestern Regional Medical Center, Zion · 6 mi lwen
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi lwen
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- ak 2 plis
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- AMG Libertyville - Oncology, Libertyville · 8 mi lwen
- Condell Memorial Hospital, Libertyville · 8 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Waukegan
- Kansè Poumon ki pa ti selil16 etid
- Kansè poumon16 etid
- Kolit Ulseratif7 etid
- Kansè renn (Kasinom selil renn)7 etid
- Kansè ovè6 etid
- Kansè Metastatik6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè kolorektal6 etid
- Kansè pwostat6 etid
- Melanom5 etid
- Leksemi mieloïd egi5 etid
- Maladi Crohn5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.